From: Epithelial-myoepithelial carcinoma: a population-based survival analysis
Primary site | ||
---|---|---|
Abdominal esophagus | 1 | 0.2% |
Accessory sinus, NOS | 1 | 0.2% |
Anterior wall of nasopharynx | 2 | 0.4% |
Axillary tail of breast | 1 | 0.2% |
Base of tongue, NOS | 2 | 0.4% |
Breast, NOS | 4 | 0.9% |
Central portion of breast | 2 | 0.4% |
Cervical esophagus | 1 | 0.2% |
Cheek mucosa | 5 | 1.1% |
Conn, subcutaneous, other soft tis: lower limb, hip | 1 | 0.2% |
Conn, subcutaneous, other soft tis: trunk, NOS | 2 | 0.4% |
Conn, subcutaneous, other soft tis: upr limb, shoulder | 1 | 0.2% |
Endometrium | 2 | 0.4% |
Ethmoid sinus | 1 | 0.2% |
External ear | 2 | 0.4% |
Floor of mouth, NOS | 2 | 0.4% |
Hard palate | 10 | 2.1% |
Head, face or neck, NOS | 1 | 0.2% |
Lacrimal gland | 1 | 0.2% |
Lateral wall of nasopharynx | 1 | 0.2% |
Lower lobe, lung | 3 | 0.6% |
Lower-inner quadrant of breast | 1 | 0.2% |
Lower-outer quadrant of breast | 1 | 0.2% |
Lung, NOS | 2 | 0.4% |
Main bronchus | 3 | 0.6% |
Major salivary gland, NOS | 14 | 3.0% |
Maxillary sinus | 5 | 1.1% |
Middle lobe, lung | 1 | 0.2% |
Mouth, NOS | 1 | 0.2% |
Nasal cavity | 6 | 1.3% |
Nasopharynx, NOS | 3 | 0.6% |
Ovary | 11 | 2.4% |
Overlapping lesion of breast | 5 | 1.1% |
Overlapping lesion of floor of mouth | 1 | 0.2% |
Overlapping lesion of lung | 1 | 0.2% |
Overlapping lesion of major salivary glands | 1 | 0.2% |
Overlapping lesion of palate | 1 | 0.2% |
Overlapping lesion of rectum, anus, and anal canal | 1 | 0.2% |
Overlapping lesion of tongue | 1 | 0.2% |
Parotid gland | 270 | 57.7% |
Posterior wall of nasopharynx | 2 | 0.4% |
Pyriform sinus | 1 | 0.2% |
Retromolar area | 1 | 0.2% |
Sigmoid colon | 1 | 0.2% |
Skin of scalp and neck | 2 | 0.4% |
Skin other/unspec parts of face | 1 | 0.2% |
Soft palate, NOS | 5 | 1.1% |
Sublingual gland | 1 | 0.2% |
Submandibular gland | 46 | 9.8% |
Tonsillar fossa | 1 | 0.2% |
Trachea | 3 | 0.6% |
Unknown primary site | 14 | 3.0% |
Upper gum | 1 | 0.2% |
Upper lobe, lung | 2 | 0.4% |
Upper-inner quadrant of breast | 2 | 0.4% |
Upper-outer quadrant of breast | 10 | 2.1% |